|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
protects nursing neonates by suppressing the production of inflammatory milk1 Howard Hughes Medical Institute, Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA; 2 The Skaggs Institute for Chemical Biology and Departments of Cell Biology and Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA
Lactation is a highly demanding lipid synthesis and transport process that is crucial for the development of newborn mammals. While PPAR
is known to promote adipogenesis and lipogenesis in adipose tissue, its role in the lactating mammary gland is unexplored. Here, we report that a targeted deletion of PPAR
in mice results in the production of "toxic milk" containing elevated levels of inflammatory lipids. Surprisingly, ingestion of this "toxic milk" causes inflammation, alopecia, and growth retardation in the nursing neonates. Genomic profiling reveals that PPAR
deficiency leads to increased expression of lipid oxidation enzymes in the lactating mammary gland. Consistently, metabolomic profiling detects increased levels of oxidized free fatty acids in the pups nursed by PPAR
-deficient mothers. Therefore, maternal PPAR
is pivotal for maintaining the quality of milk and protecting the nursing newborns by suppressing the production of inflammatory lipids in the lactating mammary gland.
[Keywords: PPARg; mammary gland; lactation; inflammation; alopecia; lipid oxidation]
Received May 3, 2007; revised version accepted June 14, 2007.
E-MAIL evans{at}salk.edu; FAX (858) 455-1349.
Supplemental material is available at http://www.genesdev.org.
Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.1567207
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. M. Lindstrom, A. R. Mohan, M. R. Johnson, and P. R. Bennett Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells Mol. Pharmacol., July 1, 2008; 74(1): 109 - 121. [Abstract] [Full Text] [PDF] |
||||